View Post

Check out the livestream of AIVL’s Australian Stigma Conference!

In News by AIVL

Watch the video here: https://www.facebook.com/AIVLInc/videos/495570829203545 Today’s conference brings together policymakers, healthcare professionals and people who use drugs to discuss how stigma impacts people who use drugs. You can get your questions and comments into the conversation by using Slido! Go to slido.com and then use the code #AIVLSTIGMA22 To see the Conference Program Schedule go to aivl.org.au/events/australian-stigma-conference AIVL is the …

View Post

International Drug Users Day 2022

In News by AIVL

November 1 marks International Drug Users Day (IDUD). Held annually, the day remembers the movements and protests against the significant lack of and access to treatments and services for people who use drugs (PWUD); particularly in terms of inadequate public health policy and response to the disproportionate rates of blood borne viruses such as hepatitis and HIV amongst communities of …

View Post

AIVL and CAHMA at the 27th Annual Remembrance Ceremony for those who lose their life to illicit drugs

In News by AIVL

On a cold and wet Monday afternoon, AIVL Policy & Project Officer Adrian Gorringe braced the wild weather and joined staff from CAHMA to attend the Family and Friends For Drug Law Reform (FFDLR) (ACT) 27th Annual Remembrance Ceremony. Bill Bush, president of the ACT Chapter of FFDLR opened the event to a considerable turnout. Despite the weather, people, families, and …

View Post

WORLD FIRST AS A NEW SYNTHETIC DRUG IDENTIFIED BY CanTEST

In News by AIVL

There is a new drug circulating around Canberra!  One reporter claims it may be so novel, there’s a high chance it has not even seen the inside of Berlin’s Berghain  Nightclub yet. A new compound, described as “Canberra Ketamine” or “CanKet” has been identified by CanTEST; the ‘face to face’, fixed site drug testing facility based in the ACT. The lead …

View Post

The decline of meth and the rise of phenyl-2-propanone (P2P)

In News by AIVL

“I don’t know that I would even call it meth anymore…” – Joe Bozenko, DEA Chemist & Professor, Shephard University.Methamphetamine is arguably the most demonised, stigmatised and generally misconceived drug in global circulation. Within the Australian context, we have all seen the confronting, graphic and gratuitously violent imagery of anti-ice advertisements, depicting ‘ice’ users in diabolical fits of rage lashing …

View Post

Drugs in sport: dissecting the untold harms of stigmatisation.

In News by AIVL

Aussies love their stimulants nearly as much as sports! We punch well above our weight on the international level. On the world stage, we just miss out on a podium finish for our average total stimulant consumption, securing 4th place at 59 doses per 1,000 people per day [following Czechia (76 doses), the United States of America (USA; 74 doses), …

View Post

International Overdose Awareness Day – 2022

In News by AIVL

International Overdose awareness day was initiated in 2001, August 31 will mark 21 years of the world’s largest annual campaign to end overdose and remember without stigma those who have died, acknowledging the grief of all those impacted by overdose, whose loved ones have died or suffered permanent injury.

View Post

Introducing DULF

In News by AIVL

DULF is a collective made up of two drug users and activists fighting against the prevailing system that stigmatizes and kills drug users. They figuratively want to burn down the existing system, replacing it with a more caring and compassionate model. Their logo of flames encircled by flames suggests they want to be at the centre of something volatile and explosive.

View Post

World Hepatitis Day- Message delivered by AIVL’s Ceo at Parliament house

In News by AIVL

AIVL and the important network of community-led organisations working in response to Blood Borne Viruses and sexually transmissible infections have, for decades utilised their limited resources to work in close partnership with each other. Not only have they been the voice of the community at a national level but have also been drivers for getting the community to both engage in healthcare and promote the uptake of harm reduction practices. We remain closely knit in our joint commitment to eliminate Hepatitis C by 2030.